Edgewise Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Go back to Edgewise Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Edgewise Therapeutics, Inc. (EWTX) Tops Q3 EPS by 1c

November 6, 2025 8:42 AM EST

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q3 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

... More